Cargando…

Expanding Neonatal Bloodspot Screening: A Multi-Stakeholder Perspective

Neonatal bloodspot screening (NBS) aims to detect treatable disorders in newborns. The number of conditions included in the screening is expanding through technological and therapeutic developments, which can result in health gain for more newborns. NBS expansion, however, also poses healthcare, eth...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, Tessa, Kater, Adriana, Jansen, Marleen, Dondorp, Wybo J., Blom, Maartje, Kemp, Stephan, Langeveld, Mirjam, Cornel, Martina C., van der Pal, Sylvia M., Henneman, Lidewij
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527172/ https://www.ncbi.nlm.nih.gov/pubmed/34692604 http://dx.doi.org/10.3389/fped.2021.706394

Ejemplares similares

Expanded Neonatal Bloodspot Screening Programmes: An Evaluation Framework to Discuss New Conditions With Stakeholders
por: Jansen, Marleen E., et al.
Publicado: (2021)

Parents’ views on accepting, declining, and expanding newborn bloodspot screening
por: van der Pal, Sylvia M., et al.
Publicado: (2022)

What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)?
por: van Schendel, Rachèl V., et al.
Publicado: (2016)

A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child
por: van den Heuvel, Lieke M., et al.
Publicado: (2023)

Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives
por: Holtkamp, Kim C.A., et al.
Publicado: (2017)

Societal implications of expanded universal carrier screening: a scoping review
por: van den Heuvel, Lieke M., et al.
Publicado: (2022)

Lay perceptions of predictive testing for diabetes based on DNA test results versus family history assessment: a focus group study
por: Wijdenes-Pijl, Miranda, et al.
Publicado: (2011)

Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
por: Holtkamp, Kim C A, et al.
Publicado: (2016)

Responsible implementation of expanded carrier screening
por: Henneman, Lidewij, et al.
Publicado: (2016)

Views of patients and parents of children with genetic disorders on population‐based expanded carrier screening
por: Woudstra, Anke J., et al.
Publicado: (2022)

Informing Parents about Newborn Screening: A European Comparison Study
por: IJzebrink, Amber, et al.
Publicado: (2021)

Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders
por: van Dijke, Ivy, et al.
Publicado: (2022)

Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide
por: Cornel, Martina C., et al.
Publicado: (2020)

Concurrent newborn hearing and genetic screening of common hearing loss variants with bloodspot-based targeted next generation sequencing in Jiangxi province
por: Luo, Haiyan, et al.
Publicado: (2022)

Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape
por: Holtkamp, Kim C.A., et al.
Publicado: (2017)

Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol
por: Nicholls, S G, et al.
Publicado: (2014)

Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study
por: Jansen, Marleen E., et al.
Publicado: (2019)

The aims of expanded universal carrier screening: Autonomy, prevention, and responsible parenthood
por: van der Hout, Sanne, et al.
Publicado: (2019)

Reflecting on Earlier Experiences with Unsolicited Findings: Points to Consider for Next-Generation Sequencing and Informed Consent in Diagnostics
por: Rigter, Tessel, et al.
Publicado: (2013)

Couples’ experiences with expanded carrier screening: evaluation of a university hospital screening offer
por: van Dijke, Ivy, et al.
Publicado: (2021)

Processing Newborn Bloodspot Screening Results for CF
por: Barben, Jürg, et al.
Publicado: (2020)

Newborn bloodspot screening in the time of COVID-19
por: Greaves, Ronda F., et al.
Publicado: (2021)

The promises of genomic screening: building a governance infrastructure. Special issue: genetics and democracy
por: Cornel, Martina C., et al.
Publicado: (2011)

The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
por: Bessey, Alice, et al.
Publicado: (2020)

Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia
por: Blom, Maartje, et al.
Publicado: (2019)

Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population
por: Conijn, Thirsa, et al.
Publicado: (2021)

Amniotic Fluid: A Perspective on Promising Advances in the Prevention and Treatment of Necrotizing Enterocolitis
por: de Kroon, Rimke Romee, et al.
Publicado: (2022)

Parental Decision-Making and Acceptance of Newborn Bloodspot Screening: An Exploratory Study
por: Nicholls, Stuart G., et al.
Publicado: (2013)

Understanding Midwives’ Preferences for Providing Information About Newborn Bloodspot Screening
por: Wright, Stuart James, et al.
Publicado: (2018)

Neonatal Lead (Pb) Exposure and DNA Methylation Profiles in Dried Bloodspots
por: Montrose, Luke, et al.
Publicado: (2020)

Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions
por: van Schendel, Rachèl V., et al.
Publicado: (2017)

Testing the circulation of expanded flaps—prevention of necrosis of expanded flaps (a clinic study)
por: Han, Tao, et al.
Publicado: (2023)

Stakeholder Perspectives on Barriers for Healthy Living for Low-Income African American Families
por: Jones, Veronnie Faye, et al.
Publicado: (2014)

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective
por: Rigter, Tessel, et al.
Publicado: (2020)

Variability in the storage and use of newborn dried bloodspots in Canada: is it time for national standards?
por: Avard, Denise, et al.
Publicado: (2006)

Assessing a New Method for Measuring Fetal Exposure to Mercury: Newborn Bloodspots
por: Nelson, Jessica W., et al.
Publicado: (2016)

Autosomal recessive disease in children of consanguineous parents: inferences from the proportion of compound heterozygotes
por: ten Kate, Leo P., et al.
Publicado: (2010)

How will new genetic technologies, such as gene editing, change reproductive decision-making? Views of high-risk couples
por: van Dijke, Ivy, et al.
Publicado: (2020)

Opinions of maternity care professionals and other stakeholders about integration of maternity care: a qualitative study in the Netherlands
por: Perdok, Hilde, et al.
Publicado: (2016)

Attitudes of relatives of mucopolysaccharidosis type III patients toward preconception expanded carrier screening
por: Nijmeijer, Stephanie C. M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eck7a6arhbqvhllp882gi9bvar